Avandia, a Case of Deja Vu all over again
Similar Posts
“The Check is in the Mail”- Lilly-Zyprexa settlement payments
8, 362 consumers of Lilly’s top-selling drug that produces diabetes–among other life-threatening effects–can expect between $5,000 to "well over $100,000 a person" depending upon the harm suffered.
AHRP Letter of complaint to Dr. Greg Koski
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) New York, NY 10023 212-595-8974 July 29, 2002 Greg Koski, MD, Ph.D. Office of the Secretary Office of Public Health and Science Office of Human Research Protection The Tower Building 1101 Wooten Parkway, Suite 200 Rockville, MD 20852 RELATED PAGES OHRP Investigation of…
Despite Accutane Suicide Risk, Judge Refuses to make company Memos Public
Despite Accutane Suicide Risk, Judge Refuses to make company Memos Public Mon, 31 Jan 2005 Judge James Moody, A federal judge in Tampa, Florida, ruled against plaintiff lawyers who sought to share internal documents belonging to Hoffman-LaRoche that show the company knew about the increased suicide risk associated with the…
Netracor J & J heart Drug May Raise Risk of Dying
Netracor J & J heart Drug May Raise Risk of Dying Wed, 20 Apr 2005 A new research challenges the safety level linked with the drug ‘Natretor.’ Scios Inc., a subsidiary of Johnson & Johnson is the maker of “Natrecor.” “Researchers say that the use of heart-failure drug Natrecor results…
Obama Administration Seeks to Test Anthrax Vaccine in Children
Whose children will be sacrificed in an illegal and unethical experiment in the name of Biodefense Preparedness?
JAMA Antidepressant Meta-analysis Reveals 22 Years of Deception
Twenty-two years after the US marketing of Prozac, JAMA meta-analysis shows antidepressants to be worthless for most of the people for whom they are prescribed.